发明名称 UREA BASED LIPOXYGENASE COMPOUNDS
摘要 Compounds of the formula: <IMG> I wherein R1 and R2 are independently selected from hydrogen, C1 to C4 alkyl, or hydroxy, but R1 and R2 are not simultaneously hydroxy; wherein X is selected from (C(R4)2)m, where m=1 to 3; wherein R4 is selected independently at each occurrence from hydrogen, or C1 to C4 alkyl, wherein R3 is <IMG> or <IMG> or <IMG> wherein Y1 is selected from (1) hydrogen, (2) C1 to C6 alkyl, (3) C2 to C6 alkenyl, (4) C1 to C6 alkoxy, (5) C3 to C8 cycloalkyl, (6) aryl, (7) aryloxy, (8) aroyl, (9) C1 to C6 arylalkyl, (10) C2 to C6 arylalkenyl, (11) C1 to C6 arylalkoxy, (12) C1 to C6 arylthioalkoxy, or substituted derivatives of (13) aryl, (14) aryloxy, (15) aroyl, (16) C1 to C6 arylalkyl, (17) C2 to C6 arylalkenyl, (18) C1 to C6 arylalkoxy, (19) C1 to C6arylthioalkoxy, wherein substituents are selected from halo, nitro, cyano, C1 to C6 alkyl, alkoxy, or halosubstituted alkyl; wherein Y2 is selected from hydrogen, halogen, hydroxy, cyano, halosubstituted alkyl, or Y1; and finally wherein M is hydrogen, a pharmaceutically acceptable cation, aroyl, or C1 to C6 alkoyl are potent inhibitors of the enzyme 5-lipoxygenase.
申请公布号 CA1336099(C) 申请公布日期 1995.06.27
申请号 CA19880564751 申请日期 1988.04.21
申请人 ABBOTT LABORATORIES 发明人 SUMMERS, JAMES B., JR.;BROOKS, DEE W.;STEWART, ANDREW O.
分类号 C07D333/20;A61K31/17;A61K31/38;A61K31/381;A61P1/00;A61P9/04;A61P11/00;A61P19/06;A61P27/16;A61P29/00;A61P37/04;A61P37/08;A61P43/00;C07C275/24;C07C275/64;(IPC1-7):C07C239/08;C07D333/04 主分类号 C07D333/20
代理机构 代理人
主权项
地址